p53 and β-Catenin Expression Predict Poorer Prognosis in Patients With Anaplastic Large-Cell Lymphoma

Aida Richardson, C. Cameron Yin, Wei Cui, Nianyi Li, L. Jeffrey Medeiros, Linheng Li, Da Zhang*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

p53 or β-catenin expression alone or β-catenin/p53 double expression showed poorer overall survival and disease-free survival in patients with anaplastic large-cell lymphoma (ALCL) overall and in patients with anaplastic lymphoma kinase–negative ALCL.

Original languageEnglish (US)
Pages (from-to)e385-e392
JournalClinical Lymphoma, Myeloma and Leukemia
Volume19
Issue number7
DOIs
StatePublished - Jul 2019

Keywords

  • ALCL
  • ALK
  • Survival
  • Wnt signaling
  • β-Catenin

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'p53 and β-Catenin Expression Predict Poorer Prognosis in Patients With Anaplastic Large-Cell Lymphoma'. Together they form a unique fingerprint.

Cite this